
Cencora's Ameer Ali explains why trading partners' systems, not the NDC-12 deadline itself, determine whether product keeps moving through the supply chain during the transition.
In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Venkatraman Balasubramanian discusses broader supply chain issues.






